Unknown

Dataset Information

0

Efficacy and safety of tocilizumab in hospitalized COVID-19 patients: a systematic review and meta-analysis.

ABSTRACT:

SUBMITTER: Luo L 

PROVIDER: S-EPMC8604568 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis.
| S-EPMC7644182 | biostudies-literature
Unknown Efficacy and Safety of Hydroxychloroquine for Hospitalized COVID-19 Patients: A Systematic Review and Meta-Analysis.
| S-EPMC8201261 | biostudies-literature
Unknown Efficacy and safety of tocilizumab in COVID-19 patients: a living systematic review and meta-analysis, first update.
| S-EPMC8076756 | biostudies-literature
Unknown Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.
| S-EPMC7646626 | biostudies-literature
Unknown Tocilizumab administration for the treatment of hospitalized patients with COVID-19: A systematic review and meta-analysis.
| S-EPMC8661720 | biostudies-literature
Unknown Tocilizumab treatment for COVID-19 patients: a systematic review and meta-analysis.
| S-EPMC8128625 | biostudies-literature
Unknown Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis.
| S-EPMC9037226 | biostudies-literature
Unknown Efficacy and safety of tocilizumab versus standard care/placebo in patients with COVID-19; a systematic review and meta-analysis of randomized clinical trials.
| S-EPMC8653234 | biostudies-literature
Unknown Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.
| S-EPMC7781101 | biostudies-literature
Unknown COVID-19 fatality rates in hospitalized patients: systematic review and meta-analysis.
| S-EPMC7920817 | biostudies-literature